Cargando…
Inhibition of tissue factor pathway inhibitor (TFPI) by ARC19499 improves clotting of hemophiliac blood
Autores principales: | Gorczyca, Monika E, Jilma, Bernd, Male, Christoph, Reitter, Sylvia, Gilbert, James C, Pabinger, Ingrid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016556/ http://dx.doi.org/10.1186/1471-2210-10-S1-A44 |
Ejemplares similares
-
The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor-mediated ex vivo platelet function in ST-elevation and non-ST-elevation acute myocardial infarction
por: Spiel, Alexander O, et al.
Publicado: (2008) -
Combination of Novoseven and Feiba in Hemophiliac Patients with Inhibitors
por: Malkan, Umit Yavuz, et al.
Publicado: (2018) -
Hypercoagulability indicated by elevated blood TFPI (tissue factor pathway inhibitor) levels is closely related to severity of septic patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2000) -
The relationship between happiness and self-rated health: A population-based study of 19499 Iranian adults
por: Mohammadi, Samira, et al.
Publicado: (2022) -
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D‐Dimer analysis: A prospective study
por: Posch, Florian, et al.
Publicado: (2020)